Clinical Manifestation and PRRT2 Analysis of Korean Patients with Paroxysmal Kinesigenic Dyskinesia
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Paroxysmal kinesigenic dyskinesia (PKD) is a rare paroxysmal movement disorder characterized by recurrent and brief dyskinesia attacks triggered by sudden voluntary movement. The diagnosis of PKD is based on clinical findings, and mutations in the proline-rich transmembrane protein 2 (PRRT2) gene have been identified as the cause of PKD. Two Korean cohorts have been reported on PRRT2 mutation analysis in PKD patients. The purpose of this study was to determine the mutation spectrum of the PRRT2 gene and to examine the clinical characteristics associated with PRRT2 mutations. Methods: We studied 23 members of four families with familial PKD and two families with sporadic PKD which included 9 patients and 2 patients, respectively. Mutation analysis of the PRRT2 gene was performed using Sanger sequencing. Clinical features of PKD were compared between patients with a PRRT2 mutation and those with no detectable PRRT2 mutation. Results: PRRT2 mutations were detected in three of four PKD families (75%), and in none of the two sporadic cases (0%). All detected PRRT2 mutations were c.649dupC (p.Arg217Profs*8). Subjects with detected PRRT2 mutations had earlier age at onset and longer duration of attacks. Conclusion: As previously reported in Korean PKD patients, our results confirmed that PRRT2 is a major causative gene for familial PKD, and the c.649dupC is the most frequent mutation. PRRT2 mutation analysis is required for the molecular diagnosis of familial PKD and for evaluating the clinical manifestations of PKD.
Abstract
Purpose: Paroxysmal kinesigenic dyskinesia (PKD) is a rare paroxysmal movement disorder characterized by recurrent and brief dyskinesia attacks triggered by sudden voluntary movement. The diagnosis of PKD is based on clinical findings, and mutations in the proline-rich transmembrane protein 2 (PRRT2) gene have been identified as the cause of PKD. Two Korean cohorts have been reported on PRRT2 mutation analysis in PKD patients. The purpose of this study was to determine the mutation spectrum of the PRRT2 gene and to examine the clinical characteristics associated with PRRT2 mutations. Methods: We studied 23 members of four families with familial PKD and two families with sporadic PKD which included 9 patients and 2 patients, respectively. Mutation analysis of the PRRT2 gene was performed using Sanger sequencing. Clinical features of PKD were compared between patients with a PRRT2 mutation and those with no detectable PRRT2 mutation. Results: PRRT2 mutations were detected in three of four PKD families (75%), and in none of the two sporadic cases (0%). All detected PRRT2 mutations were c.649dupC (p.Arg217Profs*8). Subjects with detected PRRT2 mutations had earlier age at onset and longer duration of attacks. Conclusion: As previously reported in Korean PKD patients, our results confirmed that PRRT2 is a major causative gene for familial PKD, and the c.649dupC is the most frequent mutation. PRRT2 mutation analysis is required for the molecular diagnosis of familial PKD and for evaluating the clinical manifestations of PKD.
참고문헌 (24)
- Chen WJ, "Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia", Nat Genet, 43, pp.1252~1255 (2011)
- Wang JL, "Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias", Brain, 134, pp.3493~3501 (2011)
- Liu Q, "Mutations in PRRT2result in paroxysmal dyskinesias with marked variability in clinical expression", J Med Genet, 49, pp.79~82 (2012)
- Liu XR, "Novel PRRT2 mutations in paroxysmal dyskinesia patients with variant inheritance and phenotypes", Genes Brain Behav, 12, pp.234~240 (2013)
- Méneret A, "PRRT2 mutations : a major cause of paroxysmal kinesigenic dyskinesia in the European population", Neurology, 79, pp.170~174 (2012)
- van Vliet R, "PRRT2 phenotypes and penetrance of paroxysmal kinesigenic dyskinesia and infantile convulsions", Neurology, 79, pp.777~784 (2012)
- 윤진영, "Clinical Manifestations in Paroxysmal Kinesigenic Dyskinesia Patients with Proline-Rich Transmembrane Protein 2 Gene Mutation", Journal of Clinical Neurology, 10(1), pp.50~54 (2014), 대한신경과학회[DOI]
- Ono S, "Mutations in PRRT2 responsible for paroxysmal kinesigenic dyskinesias also cause benign familial infantile convulsions", J Hum Genet, 57, pp.338~341 (2012)
- Heron SE, "PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome", Am J Hum Genet, 90, pp.152~160 (2012)
- Ebrahimi-Fakhari D, "The evolving spectrum of PRRT2-associated paroxysmal diseases", Brain, 138, pp.3476~3495 (2015)
- Seong MW, "PRRT2 mutation in Korean patients with paroxysmal kinesigenic dyskinesia : a clinico-genetic analysis", Neurol Asia, 19, pp.357~362 (2014)
- Huang XJ, "Paroxysmal kinesigenic dyskinesia : clinical and genetic analyses of 110 patients", Neurology, 85, pp.1546~1553 (2015)
- Bruno MK, "Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia : new diagnostic criteria", Neurology, 63, pp.2280~2287 (2004)
- Hackshaw A., "Small studies : strengths and limitations", Eur Respir J, 32, pp.1141~1143 (2008)
- Kertesz A, "Paroxysmal kinesigenic choreoathetosis. An entity within the paroxysmal choreoathetosis syndrome. Description of 10 cases, including 1 autopsied", Neurology, 17, pp.680~690 (1967)
- Tomita H, "Paroxysmal kinesigenic choreoathetosis locus maps to chromosome 16p11.2-q12.1", Am J Hum Genet, 65, pp.1688~1697 (1999)
- Bennett LB, "A locus for paroxysmal kinesigenic dyskinesia maps to human chromosome 16", Neurology, 54, pp.125~130 (2000)
- Lee HY, "Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions", Cell Rep, 1, pp.2~12 (2012)
- Valtorta F, "PRRT2 : from paroxysmal disorders to regulation of synaptic function", Trends Neurosci, 39, pp.668~679 (2016)
- Gardiner AR, "PRRT2 gene mutations : from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine", Neurology, 79, pp.2115~2121 (2012)
- Heron SE, "Role of PRRT2 in common paroxysmal neurological disorders : a gene with remarkable pleiotropy", J Med Genet, 50, pp.133~139 (2013)
- Stelzl U, "A human protein-protein interaction network : a resource for annotating the proteome", Cell, 122, pp.957~968 (2005)
- Gardella E, "Benign infantile seizures and paroxysmal dyskinesia caused by an SCN8A mutation", Ann Neurol, 79, pp.428~436 (2016)
- Wang HX, "Mutation analysis of MR-1, SLC2A1, and CLCN1 in 28 PRRT2-negative paroxysmal kinesigenic dyskinesia patients", Chin Med J, 129, pp.1017~1021 (2016)